Ignyta Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters??? Option To Purchase Additional Shares Post author:Sam Post published:May 9, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Genentech's Tecentriq Impresses Again in Late-Stage Kidney Cancer Trial February 5, 2018 3 Small Biotechs Big Drugmakers are Making Googly Eyes At January 28, 2018 Frazier-Backed Mavupharma Scores $20M to Fund STING Program November 28, 2017